Theratechnologies Statistics
Total Valuation
THTX has a market cap or net worth of $65.90 million. The enterprise value is $99.83 million.
Important Dates
The next estimated earnings date is Wednesday, April 9, 2025, before market open.
| Earnings Date | Apr 9, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
THTX has 45.98 million shares outstanding. The number of shares has increased by 87.46% in one year.
| Current Share Class | 45.98M |
| Shares Outstanding | 45.98M |
| Shares Change (YoY) | +87.46% |
| Shares Change (QoQ) | -0.02% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 34.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 13.96 |
| PS Ratio | 0.77 |
| Forward PS | 0.76 |
| PB Ratio | -2.61 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 27.70 |
| P/OCF Ratio | 27.70 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 9.42, with an EV/FCF ratio of 41.96.
| EV / Earnings | n/a |
| EV / Sales | 1.16 |
| EV / EBITDA | 9.42 |
| EV / EBIT | 12.21 |
| EV / FCF | 41.96 |
Financial Position
The company has a current ratio of 1.19
| Current Ratio | 1.19 |
| Quick Ratio | 0.72 |
| Debt / Equity | n/a |
| Debt / EBITDA | 4.17 |
| Debt / FCF | 19.17 |
| Interest Coverage | 0.78 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 7.79% |
| Return on Invested Capital (ROIC) | 17.49% |
| Return on Capital Employed (ROCE) | 49.60% |
| Revenue Per Employee | $833,650 |
| Profits Per Employee | -$80,641 |
| Employee Count | 103 |
| Asset Turnover | 1.31 |
| Inventory Turnover | 3.60 |
Taxes
In the past 12 months, THTX has paid $2.01 million in taxes.
| Income Tax | 2.01M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.66% in the last 52 weeks. The beta is 1.47, so THTX's price volatility has been higher than the market average.
| Beta (5Y) | 1.47 |
| 52-Week Price Change | -15.66% |
| 50-Day Moving Average | 1.63 |
| 200-Day Moving Average | 1.45 |
| Relative Strength Index (RSI) | 40.25 |
| Average Volume (20 Days) | 2,974,710 |
Short Selling Information
The latest short interest is 41,858, so 0.09% of the outstanding shares have been sold short.
| Short Interest | 41,858 |
| Short Previous Month | 48,503 |
| Short % of Shares Out | 0.09% |
| Short % of Float | 0.12% |
| Short Ratio (days to cover) | 0.33 |
Income Statement
In the last 12 months, THTX had revenue of $85.87 million and -$8.31 million in losses. Loss per share was -$0.17.
| Revenue | 85.87M |
| Gross Profit | 65.42M |
| Operating Income | 8.17M |
| Pretax Income | -6.57M |
| Net Income | -8.31M |
| EBITDA | 10.60M |
| EBIT | 8.17M |
| Loss Per Share | -$0.17 |
Full Income StatementBalance Sheet
The company has $10.79 million in cash and $45.61 million in debt, giving a net cash position of -$34.81 million or -$0.76 per share.
| Cash & Cash Equivalents | 10.79M |
| Total Debt | 45.61M |
| Net Cash | -34.81M |
| Net Cash Per Share | -$0.76 |
| Equity (Book Value) | -25.27M |
| Book Value Per Share | -0.55 |
| Working Capital | 7.12M |
Full Balance SheetCash Flow
| Operating Cash Flow | 2.38M |
| Capital Expenditures | n/a |
| Free Cash Flow | 2.38M |
| FCF Per Share | $0.05 |
Full Cash Flow StatementMargins
Gross margin is 76.19%, with operating and profit margins of 9.52% and -9.67%.
| Gross Margin | 76.19% |
| Operating Margin | 9.52% |
| Pretax Margin | -7.34% |
| Profit Margin | -9.67% |
| EBITDA Margin | 12.34% |
| EBIT Margin | 9.52% |
| FCF Margin | 2.77% |